Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) HKSE

1.24

-0.01(-0.80%)

Updated at September 08 03:13PM

Currency In HKD

Valuation

Market Cap1.73B
Enterprise Value601.73M
P/E Ratio3.01
PEG Ratio0.03
Price/Sales Ratio1.6
Price/Book Ratio0.51
Enterprise/Revenue0.54
Enterprise/EBITDA2.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.53
Operating Margin0.19

Management Effectiveness

Return On Assets0.14
Return On Equity0.17

Income Statement

Revenue1.06B
Revenue/Share0.7
Gross Profit577.63M
EBITDA280.49M
Net Income564.94M
Diluted EPS0.38

Balance Sheet

Total Cash1.37B
Total Cash/Share0.9
Total Debt34.72M
Total Debt/Equity0.01
Current Ratio3.97
Book Value Per Share2.2

Price History

52-Week Change8.85
52-Week High1.47
52-Week Low1.07
Moving Average 50 Days1.3
Moving Average 200 Days1.22

Statistics

Average Volume2.36M
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield5.12
Payout Ratio0.16
Last Split Factor2:1
Last Split DateAugust 20, 2018